Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 4;81(7):208.
doi: 10.1007/s00284-024-03748-z.

Diabetes and Infectious Diseases with a Focus on Melioidosis

Affiliations
Review

Diabetes and Infectious Diseases with a Focus on Melioidosis

Asqwin Uthaya Kumar et al. Curr Microbiol. .

Abstract

Diabetes mellitus (DM) leads to impaired innate and adaptive immune responses. This renders individuals with DM highly susceptible to microbial infections such as COVID-19, tuberculosis and melioidosis. Melioidosis is a tropical disease caused by the bacterial pathogen Burkholderia pseudomallei, where diabetes is consistently reported as the most significant risk factor associated with the disease. Type-2 diabetes is observed in 39% of melioidosis patients where the risk of infection is 13-fold higher than non-diabetic individuals. B. pseudomallei is found in the environment and is an opportunistic pathogen in humans, often exhibiting severe clinical manifestations in immunocompromised patients. The pathophysiology of diabetes significantly affects the host immune responses that play a critical role in fighting the infection, such as leukocyte and neutrophil impairment, macrophage and monocyte inhibition and natural killer cell dysfunction. These defects result in delayed recruitment as well as activation of immune cells to target the invading B. pseudomallei. This provides an advantage for the pathogen to survive and adapt within the immunocompromised diabetic patients. Nevertheless, knowledge gaps on diabetes-infectious disease comorbidity, in particular, melioidosis-diabetes comorbidity, need to be filled to fully understand the dysfunctional host immune responses and adaptation of the pathogen under diabetic conditions to guide therapeutic options.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Tan SY, Mei Wong JL, Sim YJ, Wong SS, Mohamed Elhassan SA, Tan SH, Ling Lim GP, Rong Tay NW, Annan NC, Bhattamisra SK, Candasamy M (2019) Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr 13(1):364–372. https://doi.org/10.1016/j.dsx.2018.10.008 - DOI - PubMed
    1. Kahaly GJ, Hansen MP (2016) Type 1 diabetes associated autoimmunity. Autoimmun Rev 15(7):644–648. https://doi.org/10.1016/j.autrev.2016.02.017 - DOI - PubMed
    1. Muoio DM, Newgard CB (2008) Mechanisms of disease: Molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes. Nat Rev Mol Cell Biol 9(3):193–205. https://doi.org/10.1038/nrm2327 - DOI - PubMed
    1. Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martin C (2020) Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci 21(17):6275. https://doi.org/10.3390/2Fijms21176275 - DOI - PubMed - PMC
    1. Global Burden of Disease Collaborative Network (2020) Global Burden of Disease Study 2019 Results. https://vizhub.healthdata.org/gbd-results/ . Accessed 1 Apr 2024

MeSH terms

LinkOut - more resources